Plinabulin
Plinabulin
Plinabulin (pronunciation: pli-na-bu-lin) is a small molecule drug candidate that is being developed for the treatment of cancer and the prevention of chemotherapy-induced neutropenia.
Etymology
The name "Plinabulin" is derived from the Latin words "plina" meaning "full" and "bulin" referring to the drug's ability to inhibit the growth of cancer cells.
Usage
Plinabulin is currently being studied in clinical trials for its potential use in the treatment of various types of cancer, including lung cancer, breast cancer, and colorectal cancer. It is also being investigated for its potential to prevent chemotherapy-induced neutropenia, a common and serious side effect of cancer treatment.
Mechanism of Action
Plinabulin works by disrupting the formation of the microtubules in cancer cells, which are essential for cell division and growth. This disruption prevents the cancer cells from dividing and growing, thereby inhibiting the progression of the disease.
Related Terms
External links
- Medical encyclopedia article on Plinabulin
- Wikipedia's article - Plinabulin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski